Analyst Ratings for Reviva Pharmaceuticals (RVPH)
RVPH Rating Summary
RVPH Price Target Summary
- Highest: $7.00 (Benchmark)
- Lowest: $2.00 (Maxim Group)
- Average: $3.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$3.75 (+1983.3%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
Avg. $ Target:
$3.75 (+1983.3%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | D. Boral Capital | Jason Kolbert | Downgrade | Hold (Buy) |
N/A (N/A) |
0.24 (0.18) |
-25% | Details |
| 1/5/2026 | Chardan | Keay Nakae | New Coverage | Buy (N/A) |
2.00 (N/A) |
0.28 (0.18) |
-35.71% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
